Fosun Pharma Stock - analyst consensus and technical picture on a quiet news day
18.06.2026 - 22:53:13 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 20:45 UTC. Details in the imprint.
Fosun Pharma (CNE100000536) remains without a new market-moving corporate announcement today. Instead, investors are looking to existing analyst estimates and the current chart picture at the Hong Kong and Shanghai listings as key reference points.
Background and data on Fosun Pharma stock
All corporate news, regulatory disclosures and market data on Fosun Pharma stock are aggregated in our topic overview for a structured view of the Chinese healthcare group.
What recent data show
Fosun Pharma stock is listed in Shanghai under ticker 600196 and in Hong Kong under code 2196, giving investors access in both CNY and HKD. Recent quote data show the Shanghai shares around the low-20s CNY per share.
MarketScreener and other financial platforms continue to flag Fosun Pharma within the pharmaceuticals and healthcare space, with the stock down year-to-date compared with its level at the start of the year. That aligns with a more cautious sentiment toward some Chinese healthcare names in 2026.
Analyst consensus snapshot
Analyst services compiled on MarketScreener indicate that brokers still cover Fosun Pharma with a range of target prices above and below current trading levels, though the average target remains above the latest Shanghai close. Ratings cluster largely between "Buy" and "Hold" on the stock.
Consensus estimates point to continued revenue from its diversified pharmaceutical and healthcare services portfolio, with expectations for gradual earnings growth over the coming years according to the compiled forecasts. Ultimately, these are projections and can change as new data emerge.
The current technical picture
On the technical side, Fosun Pharma shares in Shanghai recently traded in the low-20s CNY, with five-day performance modestly negative and year-to-date performance weaker, according to summary quote data. Short-term fluctuations remain relatively contained, suggesting a muted trading range in recent sessions.
Against this backdrop, the Hong Kong listing around the mid-teens HKD per share mirrors a similar directional pattern, reflecting both company-specific sentiment and broader moves in Chinese healthcare stocks. For many chart-focused investors, previous lows and the behavior around moving averages act as orientation levels rather than as firm signals.
How the company makes money
Fosun Pharma generates revenue across prescription drugs, medical devices, diagnostics and healthcare services, with a strong presence in China and selected international markets. A representative product line is its portfolio of anti-infective and chronic disease medications marketed through hospitals and pharmacies.
Where the stock trades today
The shares of Fosun Pharma (CNE100000536) last traded on the Shanghai Stock Exchange around CNY 21.58 per share and on the Hong Kong Stock Exchange around HKD 15.75 per share, based on the most recently available delayed data as of 06/18/2026.
Fosun Pharma at a glance
- Company: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- ISIN: CNE100000536
- WKN: A1JLV5
- Ticker: 600196 (Shanghai), 2196 (Hong Kong)
- Venue: Shanghai Stock Exchange / Hong Kong Stock Exchange
- Price (as of 06/18/2026, 20:45 UTC): 21.58 CNY (Shanghai), 15.75 HKD (Hong Kong)
- Market cap: approximately in the mid-billions CNY, based on recent share prices and shares outstanding
- Sector / Industry: Healthcare - Pharmaceuticals
- Index membership: included in major Chinese A-share and Hong Kong healthcare and pharmaceutical indices where applicable
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
